Home

tájékoztat mikroprocesszor távolsági busz isoniazid egér Elrontott Bájos Űrhajó

Hepatoprotective effects of Malus hupehensis tea against isoniazid- and  rifampicin-induced liver injury by regulating cytochrome P450 in mice -  ScienceDirect
Hepatoprotective effects of Malus hupehensis tea against isoniazid- and rifampicin-induced liver injury by regulating cytochrome P450 in mice - ScienceDirect

Xanthohumol from Humulus lupulus L. potentiates the killing of  Mycobacterium tuberculosis and mitigates liver toxicity by the combination  of isoniazid ... - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10347C
Xanthohumol from Humulus lupulus L. potentiates the killing of Mycobacterium tuberculosis and mitigates liver toxicity by the combination of isoniazid ... - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10347C

Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and  Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical  Research in Toxicology
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology

Modeling early bactericidal activity in murine tuberculosis provides  insights into the activity of isoniazid and pyrazinamide | PNAS
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide | PNAS

JCI Insight - Interleukin-17 limits hypoxia-inducible factor 1α and  development of hypoxic granulomas during tuberculosis
JCI Insight - Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis

Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA  Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model |  Antimicrobial Agents and Chemotherapy
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model | Antimicrobial Agents and Chemotherapy

Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin  and Isoniazid
Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin and Isoniazid

Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and  Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical  Research in Toxicology
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology

Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA  Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model |  Antimicrobial Agents and Chemotherapy
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model | Antimicrobial Agents and Chemotherapy

A Physiologically Based Pharmacokinetic Model of Isoniazid and Its  Application in Individualizing Tuberculosis Chemotherapy | Antimicrobial  Agents and Chemotherapy
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy | Antimicrobial Agents and Chemotherapy

Studies of the Specific Activity of Aerosolized Isoniazid against  Tuberculosis in a Mouse Model
Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model

Mycobacterium tuberculosis persistence mutants identified by screening in  isoniazid-treated mice | PNAS
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice | PNAS

Assessing whether isoniazid is essential during the first 14 days of  tuberculosis therapy: a phase 2a, open-label, randomised controlled trial -  ScienceDirect
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial - ScienceDirect

Modeling early bactericidal activity in murine tuberculosis provides  insights into the activity of isoniazid and pyrazinamide | PNAS
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide | PNAS

Isonicotinylation is a histone mark induced by the anti-tuberculosis  first-line drug isoniazid | Nature Communications
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid | Nature Communications

Assessing whether isoniazid is essential during the first 14 days of  tuberculosis therapy: a phase 2a, open-label, randomised controlled trial -  ScienceDirect
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial - ScienceDirect

Isoniazid Oral Solution - CMP Pharma
Isoniazid Oral Solution - CMP Pharma

Treatment of Tuberculosis Using a Combination of Sustained-Release  Rifampin-Loaded Microspheres and Oral Dosing with Isoniazid | Antimicrobial  Agents and Chemotherapy
Treatment of Tuberculosis Using a Combination of Sustained-Release Rifampin-Loaded Microspheres and Oral Dosing with Isoniazid | Antimicrobial Agents and Chemotherapy

pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis  Treatment in Mice - Hwang - 2015 - Small - Wiley Online Library
pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice - Hwang - 2015 - Small - Wiley Online Library

Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and  Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical  Research in Toxicology
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology

Xanthohumol from Humulus lupulus L. potentiates the killing of  Mycobacterium tuberculosis and mitigates liver toxicity by the combination  of isoniazid ... - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10347C
Xanthohumol from Humulus lupulus L. potentiates the killing of Mycobacterium tuberculosis and mitigates liver toxicity by the combination of isoniazid ... - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10347C

Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and  Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical  Research in Toxicology
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology

A Physiologically Based Pharmacokinetic Model of Isoniazid and Its  Application in Individualizing Tuberculosis Chemotherapy | Antimicrobial  Agents and Chemotherapy
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy | Antimicrobial Agents and Chemotherapy

Isonicotinylation is a histone mark induced by the anti-tuberculosis  first-line drug isoniazid | Nature Communications
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid | Nature Communications